Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: adapting Pre-MEASURE to clinical practice. - Shaffer BC; Kebriaei P; de Lima M; Jimenez Jimenez AM (Bone marrow transplantation, 2025)